- Home
- GYRE vs THR Comparison
GYRE vs THR Comparison
Compare GYRE & THR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GYRE
- THR
- Stock Information
- Founded
- GYRE 2002
- THR 1954
- Country
- GYRE United States
- THR United States
- Employees
- GYRE N/A
- THR N/A
- Industry
- GYRE Biotechnology: Pharmaceutical Preparations
- THR Industrial Machinery/Components
- Sector
- GYRE Health Care
- THR Energy
- Exchange
- GYRE Nasdaq
- THR Nasdaq
- Market Cap
- GYRE 897.1M
- THR 906.5M
- IPO Year
- GYRE N/A
- THR 2011
- Fundamental
- Price
- GYRE $7.42
- THR $28.13
- Analyst Decision
- GYRE
- THR
- Analyst Count
- GYRE 0
- THR 0
- Target Price
- GYRE N/A
- THR N/A
- AVG Volume (30 Days)
- GYRE 253.7K
- THR 222.7K
- Earning Date
- GYRE 08-12-2025
- THR 08-06-2025
- Dividend Yield
- GYRE N/A
- THR N/A
- EPS Growth
- GYRE N/A
- THR 3.97
- EPS
- GYRE 0.02
- THR 1.57
- Revenue
- GYRE $100,643,000.00
- THR $498,207,000.00
- Revenue This Year
- GYRE $21.04
- THR $6.11
- Revenue Next Year
- GYRE $89.64
- THR $5.40
- P/E Ratio
- GYRE $93.77
- THR $17.69
- Revenue Growth
- GYRE N/A
- THR 0.72
- 52 Week Low
- GYRE $6.11
- THR $23.05
- 52 Week High
- GYRE $19.00
- THR $34.36
- Technical
- Relative Strength Index (RSI)
- GYRE 39.71
- THR 55.72
- Support Level
- GYRE $7.26
- THR $27.03
- Resistance Level
- GYRE $8.00
- THR $27.70
- Average True Range (ATR)
- GYRE 0.49
- THR 0.64
- MACD
- GYRE -0.07
- THR 0.05
- Stochastic Oscillator
- GYRE 10.36
- THR 86.84
About GYRE Gyre Therapeutics Inc.
Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.
About THR Thermon Group Holdings Inc.
Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.